578 related articles for article (PubMed ID: 19385382)
1. Medical therapy of IBD in 2009.
Harris A; Feller ER; Shah SA
Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
[No Abstract] [Full Text] [Related]
2. The future of inflammatory bowel disease care.
Sandborn WJ
Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
[TBL] [Abstract][Full Text] [Related]
3. Position statement: immunomodulator therapy for inflammatory Bowel disease.
Lavy A; Chowers Y; Odes HS; Eliakim R;
Isr Med Assoc J; 2003 Mar; 5(3):164-9. PubMed ID: 12725133
[No Abstract] [Full Text] [Related]
4. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Sandborn WJ
Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
[No Abstract] [Full Text] [Related]
5. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic inflammatory bowel diseases].
Lémann M
Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Moffatt DC; Bernstein CN
Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
[TBL] [Abstract][Full Text] [Related]
8. General principles of medical therapy of inflammatory bowel disease.
Friedman S
Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic options in the inflammatory bowel disease world.
Noble A; Baldassano R; Mamula P
Dig Liver Dis; 2008 Jan; 40(1):22-31. PubMed ID: 17988966
[TBL] [Abstract][Full Text] [Related]
10. Managing the glucocorticoid dependent inflammatory bowel disease patient.
Bonner GF
Semin Gastrointest Dis; 2001 Oct; 12(4):237-44. PubMed ID: 11726077
[TBL] [Abstract][Full Text] [Related]
11. Review article: remission rates achievable by current therapies for inflammatory bowel disease.
Peyrin-Biroulet L; Lémann M
Aliment Pharmacol Ther; 2011 Apr; 33(8):870-9. PubMed ID: 21323689
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
Siegmund B; Zeitz M
Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
[TBL] [Abstract][Full Text] [Related]
13. Medical management of the pregnant patient with inflammatory bowel disease.
Steinlauf AF; Present DH
Gastroenterol Clin North Am; 2004 Jun; 33(2):361-85, xi. PubMed ID: 15177544
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance in inflammatory bowel diseases.
Moreau J; Mas E
Curr Opin Pharmacol; 2015 Dec; 25():56-61. PubMed ID: 26645664
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of Crohn disease].
Niemelä S
Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
[No Abstract] [Full Text] [Related]
16. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
17. [Present states of development in new drugs and treatment of inflammatory bowel disease].
Asakura H; Sugimura K
Nihon Rinsho; 1999 Nov; 57(11):2490-5. PubMed ID: 10572418
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy of inflammatory bowel diseases].
Silvennoinen J; Niemelä S
Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
[No Abstract] [Full Text] [Related]
19. [Maintaining a remission].
Fleig WE;
Z Gastroenterol; 2003 Jan; 41(1):36-42. PubMed ID: 12541172
[No Abstract] [Full Text] [Related]
20. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
Danese S; Angelucci E
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
